Aminologics Statistics

Total Valuation

Aminologics has a market cap or net worth of KRW 82.65 billion. The enterprise value is 45.95 billion.

Market Cap	82.65B
Enterprise Value	45.95B

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Aminologics has 87.83 million shares outstanding. The number of shares has increased by 0.59% in one year.

Current Share Class	87.83M
Shares Outstanding	87.83M
Shares Change (YoY)	+0.59%
Shares Change (QoQ)	-1.74%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	0.19%
Float	59.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.98
PB Ratio	1.52
P/TBV Ratio	1.61
P/FCF Ratio	64.92
P/OCF Ratio	46.38
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-79.14
EV / Sales	2.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	36.09

Financial Position

The company has a current ratio of 13.05, with a Debt / Equity ratio of 0.04.

Current Ratio	13.05
Quick Ratio	11.35
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	1.54
Interest Coverage	-20.79

Financial Efficiency

Return on equity (ROE) is -1.05% and return on invested capital (ROIC) is -1.90%.

Return on Equity (ROE)	-1.05%
Return on Assets (ROA)	-1.82%
Return on Invested Capital (ROIC)	-1.90%
Return on Capital Employed (ROCE)	-3.16%
Revenue Per Employee	448.14M
Profits Per Employee	-15.69M
Employee Count	38
Asset Turnover	0.28
Inventory Turnover	1.83

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.97% in the last 52 weeks. The beta is 0.96, so Aminologics's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	-34.97%
50-Day Moving Average	930.64
200-Day Moving Average	1,033.09
Relative Strength Index (RSI)	51.47
Average Volume (20 Days)	71,510

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aminologics had revenue of KRW 16.58 billion and -580.56 million in losses. Loss per share was -6.61.

Revenue	16.58B
Gross Profit	3.85B
Operating Income	-1.74B
Pretax Income	-126.87M
Net Income	-580.56M
EBITDA	-1.26B
EBIT	-1.74B
Loss Per Share	-6.61

Full Income Statement

Balance Sheet

The company has 38.66 billion in cash and 1.96 billion in debt, giving a net cash position of 36.70 billion or 417.85 per share.

Cash & Cash Equivalents	38.66B
Total Debt	1.96B
Net Cash	36.70B
Net Cash Per Share	417.85
Equity (Book Value)	54.33B
Book Value Per Share	618.63
Working Capital	46.84B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.78 billion and capital expenditures -509.00 million, giving a free cash flow of 1.27 billion.

Operating Cash Flow	1.78B
Capital Expenditures	-509.00M
Free Cash Flow	1.27B
FCF Per Share	14.49

Full Cash Flow Statement

Margins

Gross margin is 23.24%, with operating and profit margins of -10.50% and -3.50%.

Gross Margin	23.24%
Operating Margin	-10.50%
Pretax Margin	-0.77%
Profit Margin	-3.50%
EBITDA Margin	-7.61%
EBIT Margin	-10.50%
FCF Margin	7.68%

Dividends & Yields

Aminologics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.59%
Shareholder Yield	n/a
Earnings Yield	-0.70%
FCF Yield	1.54%

Stock Splits

The last stock split was on October 23, 2009. It was a forward split with a ratio of 5.

Last Split Date	Oct 23, 2009
Split Type	Forward
Split Ratio	5

Scores

Aminologics has an Altman Z-Score of 13.09.

Altman Z-Score	13.09
Piotroski F-Score	n/a